Patents by Inventor Philip Lecane

Philip Lecane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Suppression of prostate cancer using a targeted clostridial neurotoxin
    Patent number: 10550377
    Abstract: The present invention relates to a method for suppressing or treating cancer, in particular to a method for suppressing or treating one or more of colorectal cancer, breast cancer, prostate cancer and/or lung cancer. The therapy employs use of a non-cytotoxic protease, which is targeted to a growth hormone-secreting cell such as to a pituitary cell. When so delivered, the protease is internalised and inhibits secretion/transmission of growth hormone from said cell. The present invention also relates to polypeptides and nucleic acids for use in said methods.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: February 4, 2020
    Assignee: IPSEN BIOINNOVATION LIMITED
    Inventors: Frederic Madec, Philip Lecane, Philip Marks, Keith Foster
  • SUPPRESSION OF CANCER
    Publication number: 20190127718
    Abstract: Polypeptides for use in suppressing cancer and cancer disorders and methods of treatment using such polypeptides.
    Type: Application
    Filed: September 10, 2018
    Publication date: May 2, 2019
    Applicant: Ipsen Bioinnovation Limited
    Inventors: Frederic Madec, Philip Lecane, Philip Marks, Keith Foster
  • Suppression of cancer
    Patent number: 10113159
    Abstract: The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalized and inhibits secretion from the cancer cell.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: October 30, 2018
    Assignee: Ipsen Bioinnovation Limited
    Inventors: Frederic Madec, Philip Lecane, Philip Marks, Keith Foster
  • SUPPRESSION OF CANCER
    Publication number: 20140286925
    Abstract: The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell.
    Type: Application
    Filed: June 4, 2014
    Publication date: September 25, 2014
    Applicant: Syntaxin Limited
    Inventors: Frederic MADEC, Philip LECANE, Philip MARKS, Keith FOSTER
  • SUPPRESSION OF CANCER
    Publication number: 20110262423
    Abstract: The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell.
    Type: Application
    Filed: November 17, 2009
    Publication date: October 27, 2011
    Applicant: SYNTAXIN LIMITED
    Inventors: Frederic Madec, Philip Lecane, Philip Mark, Keith Foster